Alternatively, other facets of tumor pathophysiology, such as tumor hypoxia, may favorably influence the radio-response in vivo, with DNA-PKcs inhibition potentially having a preferential radiosensitizing effect in hypoxic tumor cells (46), which would otherwise represent a more radioresistant population. Here, PRKDC is linked to neoplasm.